Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence
- PMID: 22442342
- DOI: 10.1258/ebm.2011.011358
Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence
Abstract
Inflammatory bowel disease (IBD) comprises primarily the chronic relapsing inflammatory disorders, Crohn's disease and ulcerative colitis, with the former affecting any part of the gastrointestinal tract and the latter mainly afflicting the colon. The precise etiology of IBD remains unclear, and it is thought that interactions among various factors, including genetic factors, the host immune system and environmental factors, cause disruption of intestinal homeostasis, leading to dysregulated inflammatory responses of the gut. As inflammation is intimately related to formation of reactive intermediates, including reactive oxygen and nitrogen species (ROS/RNS), oxidative stress has been proposed as a mechanism underlying the pathophysiology of IBD. This review is intended to summarize succinctly recent new experimental and clinical evidence supporting oxidative stress as a pathophysiological component of IBD and point to the potential of using antioxidant compounds as promising therapeutic modalities of human IBD. The sources of ROS/RNS and the redox signaling mechanism underlying oxidative stress and inflammation in IBD are discussed to provide insight into the molecular basis of oxidative stress as a pathophysiological factor in IBD.
Similar articles
-
The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: Clinical aspects and animal models.Saudi J Gastroenterol. 2016 Jan-Feb;22(1):3-17. doi: 10.4103/1319-3767.173753. Saudi J Gastroenterol. 2016. PMID: 26831601 Free PMC article. Review.
-
Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.Gastroenterol Clin North Am. 1995 Sep;24(3):475-507. Gastroenterol Clin North Am. 1995. PMID: 8809232 Review.
-
Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.J Pathol. 2003 Sep;201(1):28-36. doi: 10.1002/path.1409. J Pathol. 2003. PMID: 12950014
-
Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease.J Pathol. 1998 Dec;186(4):416-21. doi: 10.1002/(SICI)1096-9896(199812)186:4<416::AID-PATH201>3.0.CO;2-U. J Pathol. 1998. PMID: 10209492
-
Oxidative Stress and DNA Damage: Implications in Inflammatory Bowel Disease.Inflamm Bowel Dis. 2015 Oct;21(10):2403-17. doi: 10.1097/MIB.0000000000000506. Inflamm Bowel Dis. 2015. PMID: 26193347 Review.
Cited by
-
Caffeic Acid Supplement Alleviates Colonic Inflammation and Oxidative Stress Potentially Through Improved Gut Microbiota Community in Mice.Front Microbiol. 2021 Nov 16;12:784211. doi: 10.3389/fmicb.2021.784211. eCollection 2021. Front Microbiol. 2021. PMID: 34867926 Free PMC article.
-
Genetic variants associated with Crohn's disease.Appl Clin Genet. 2013 Jul 16;6:25-32. doi: 10.2147/TACG.S33966. Print 2013. Appl Clin Genet. 2013. PMID: 23935379 Free PMC article.
-
Novel drug delivery systems for inflammatory bowel disease.World J Gastroenterol. 2022 May 14;28(18):1922-1933. doi: 10.3748/wjg.v28.i18.1922. World J Gastroenterol. 2022. PMID: 35664964 Free PMC article. Review.
-
Protective effects of conventional and colon-targeted lycopene and linalool on ulcerative colitis induced by acetic acid in rats.Inflammopharmacology. 2018 May 7. doi: 10.1007/s10787-018-0485-x. Online ahead of print. Inflammopharmacology. 2018. PMID: 29736689
-
Fucoidan enhances intestinal barrier function by upregulating the expression of claudin-1.World J Gastroenterol. 2013 Sep 7;19(33):5500-7. doi: 10.3748/wjg.v19.i33.5500. World J Gastroenterol. 2013. PMID: 24023493 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
